HRA Pharma, which is the French manufacturer of Norlevo, told Mother Jones that European pharmaceutical regulators approved their request to change their packaging information on Nov. 10.

French manufacturer HRA Pharma was conducting research on another topic related to its emergency contraceptive Norlevo when scientists realized there was “a clear impact of weight” on the drug ...

At that time Norlevo’s manufacturer, HRA Pharma, said that European pharmaceutical regulators had approved a request to change the pill's packaging label to warn women that Norlevo was not ...

The decision by HRA Pharma follows a publication of results of a study of levonorgestrel, one of the active ingredients in its Norlevo emergency contraceptive, said Frederique Welgryn, HRA Pharma ...

A CONTRACEPTIVE maker will warn women that its morning-after pill is ineffective when taken by women who weigh more than 80kg. The decision by HRA Pharma follows a publication of results of a ...

The pill, a drug called NorLevo that’s manufactured by HRA Pharma, will soon come with a warning label: HRA Pharma began investigating the need to change Norlevo’s label after Anna Glasier ...

The decision by HRA Pharma follows a publication of results of a study of levonorgestrel, one of the active ingredients in its Norlevo emergency contraceptive, said Frederique Welgryn, HRA Pharma ...

In November, French drug maker HRA Pharma announced its morning-after pill Norlevo was less effective in women weighing more than 75 kilograms (165 pounds) and that it didn’t work for women more ...